These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


92 related items for PubMed ID: 336581

  • 21. Steroid withdrawal after long-term medication for immunosuppressive therapy in renal transplant patients: adrenal response and clinical implications.
    Miozzari M, Ambühl PM.
    Nephrol Dial Transplant; 2004 Oct; 19(10):2615-21. PubMed ID: 15280521
    [Abstract] [Full Text] [Related]

  • 22. Glaucoma, miotic therapy and cataract. I. The frequency of anterior subcapsular vacuoles in glaucoma eyes treated with echothiophate (Phospholine Iodide), pilocarpine or pilocarpine-eserine, and in nonglaucomatous untreated eyes with common senile cataract.
    Axelsson U.
    Acta Ophthalmol (Copenh); 1968 Oct; 46(1):83-98. PubMed ID: 5694669
    [No Abstract] [Full Text] [Related]

  • 23. Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
    Chang SH, Russ GR, Chadban SJ, Campbell S, McDonald SP.
    Nephrology (Carlton); 2008 Apr; 13(2):171-6. PubMed ID: 18275507
    [Abstract] [Full Text] [Related]

  • 24. Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy.
    Olivari MT, Antolick A, Ring WS.
    J Heart Transplant; 1989 Apr; 8(1):34-9. PubMed ID: 2647929
    [Abstract] [Full Text] [Related]

  • 25. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
    Jazzar A, Fagiuoli S, Sisson S, Zuhdi N, Cooper DK.
    Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743
    [Abstract] [Full Text] [Related]

  • 26. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation.
    Olivari MT, Jessen ME, Baldwin BJ, Horn VP, Yancy CW, Ring WS, Rosenblatt RL.
    J Heart Lung Transplant; 1995 Aug; 14(1 Pt 1):127-35. PubMed ID: 7727461
    [Abstract] [Full Text] [Related]

  • 27. Ocular changes in renal transplant patients.
    Hovland KR, Ellis PP.
    Am J Ophthalmol; 1967 Feb; 63(2):283-9. PubMed ID: 5335424
    [No Abstract] [Full Text] [Related]

  • 28. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI, Flechner SM, Van Buren CT, Kerman RH, Kahan BD.
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract] [Full Text] [Related]

  • 29. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
    Crowson MC, Berisa F, McGonigle RJ, Adu D, Michael J, Barnes AD.
    Nephrol Dial Transplant; 1989 Aug; 4(2):129-32. PubMed ID: 2496354
    [Abstract] [Full Text] [Related]

  • 30. [Steroid glaucoma after renal transplantation (author's transl)].
    Kopsa H, Bettelheim H, Schmidt P, Zazgornik J.
    Dtsch Med Wochenschr; 1974 Mar 22; 99(12):576-7. PubMed ID: 4599073
    [No Abstract] [Full Text] [Related]

  • 31. [Cortisone cataract after renal transplantation].
    Mahlich J, Thiel G, Dobrivojevic D, Brunner F, Enderlin F.
    Dtsch Med Wochenschr; 1972 Jun 02; 97(22):860-5. PubMed ID: 4555724
    [No Abstract] [Full Text] [Related]

  • 32. Posterior subcapsular cataracts: posttransplantation in children.
    Fine RN, Offner G, Wilson WA, Mickey MR, Pennisi AF, Malekzadeh MH.
    Ann Surg; 1975 Nov 02; 182(5):585-9. PubMed ID: 1103758
    [Abstract] [Full Text] [Related]

  • 33. Effect of alternate-day steroids on renal transplant function. A controlled study.
    McDonald FD, Horensten ML, Mayor GB, Turcotte JG, Selezinka W, Schork MA.
    Nephron; 1976 Nov 02; 17(6):415-29. PubMed ID: 796739
    [Abstract] [Full Text] [Related]

  • 34. Influence of cyclosporin on steroid-induced cataracts after renal transplantation.
    Nakamura T, Sasaki H, Nagai K, Fujisawa K, Sasaki K, Suzuki K, Tsugawa R.
    Jpn J Ophthalmol; 2003 Nov 02; 47(3):254-9. PubMed ID: 12782160
    [Abstract] [Full Text] [Related]

  • 35. The concept of corticosteroid cataractogenic factor revisited.
    Fournier C, Milot JA, Clermont MJ, O'Regan S.
    Can J Ophthalmol; 1990 Dec 02; 25(7):345-7. PubMed ID: 2090339
    [Abstract] [Full Text] [Related]

  • 36. Steroid cataract--a review and a conclusion.
    Lubkin VL.
    J Asthma Res; 1977 Jan 02; 14(2):55-9. PubMed ID: 324969
    [No Abstract] [Full Text] [Related]

  • 37. Cataracts in pediatric renal transplant recipients.
    Walman GB, Chisholm L, Arbus GS.
    Can Med Assoc J; 1977 Dec 03; 117(11):1257, 1259. PubMed ID: 336167
    [No Abstract] [Full Text] [Related]

  • 38. [Ocular complications after renal transplantation].
    Shimmyo A, Miyazaki S, Onoe S, Nojima M, Ihara H, Ikoma F.
    Nippon Ganka Gakkai Zasshi; 1997 Mar 03; 101(3):220-6. PubMed ID: 9086740
    [Abstract] [Full Text] [Related]

  • 39. [Influence of cyclosporin on steroid-induced cataract].
    Nakamura T, Sasaki H, Nagai K, Fujisawa K, Sasaki K, Suzuki K, Tsugawa R.
    Nippon Ganka Gakkai Zasshi; 2001 Jul 03; 105(7):478-82. PubMed ID: 11510113
    [Abstract] [Full Text] [Related]

  • 40. [Eye and corticosteroid's use].
    Fel A, Aslangul E, Le Jeunne C.
    Presse Med; 2012 Apr 03; 41(4):414-21. PubMed ID: 22377461
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.